BTK Inhibitors in Multiple Sclerosis Treatment
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
You May Also Like
The Human Upgrade: Biohacking for Longevity & Performance
Dave Asprey
Wealth Mindset Mornings | Daily Affirmations
Motivation
The Resilient Man | Daily Stoic Affirmations
Motivation
Masculine Mindset | Affirmations for Men
Motivation
Feminine Power Affirmations
Motivation
The Dopamine Detox
Motivation
Mindset Reset | Daily Motivation
Motivation
Speak with Power | Daily Confidence Boost
Motivation
Mental Gym Daily | Train Your Toughness
Motivation
High Value Male | Mindset for Men
Motivation
The Human Upgrade: Biohacking for Longevity & Performance
Dave Asprey
Wealth Mindset Mornings | Daily Affirmations
Motivation
The Resilient Man | Daily Stoic Affirmations
Motivation
Masculine Mindset | Affirmations for Men
Motivation
Feminine Power Affirmations
Motivation
The Dopamine Detox
Motivation
Mindset Reset | Daily Motivation
Motivation
Speak with Power | Daily Confidence Boost
Motivation
Mental Gym Daily | Train Your Toughness
Motivation
High Value Male | Mindset for Men
Motivation
Community discussion